Liver cyst infection in kidney transplant patient with autosomal dominant polycystic kidney disease: Interest of PET/CT in diagnosis and treatment
Article Sidebar
Main Article Content
Abstract
Liver cyst infection in patients with autosomal dominant polycystic kidney disease (ADPKD) is a rare but life-threatening complication. Diagnosis and treatment remain challenging. We report the case of a 64-year-old kidney transplant patient presenting with fever and abdominal pain. The diagnosis of liver cyst infection was made by positron emission tomography scan (PET/CT). Moreover, the course of our patient illustrates the interest of subsequent PET/CT during follow-up as our patient failed on antibiotherapy and required liver cyst drainage.
Article Details
Copyright (c) 2018 Georgery H, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Clinical Nephrology is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.
License: Copyright © 2017 - 2025 | 
Open Access by Journal of Clinical Nephrology is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.
With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.
Compliance 'CC BY' license helps in:
| Permission to read and download | ✓ |
| Permission to display in a repository | ✓ |
| Permission to translate | ✓ |
| Commercial uses of manuscript | ✓ |
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
Gall TM, Oniscu GC, Madhavan K, Parks RW, Garden OJ. Surgical management and longterm follow‐up of non‐parasitic hepatic cysts. HBP (Oxford). 2009; 11: 235-241. Ref.: https://goo.gl/nXsEUK
Pirson Y, Kanaan N. Complications infectieuses associées à la polykystose rénale autosomique dominante. Nephrol ther. 2015; 11: 73-77. Ref.: https://goo.gl/7XVxEt
Lantinga MA, Geudens A, Gevers TJG, Drenth JPH. Systematic review: the management of hepatic cyst infection. Aliment Pharmacol Ther. 2015; 41: 253–261. Ref.: https://goo.gl/B33yyd
Sallee M, Rafat C, Zahar JR, Paulmier B, Grunfeld JP, et al. Cyst infections in patients with Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2009; 4: 1183-1189. Ref.: https://goo.gl/UKhJVJ
Lantinga MA, De Sevaux RG, Drenth JP. 18F-FDG PET/CT during diagnosis and followup of recurrent hepatic cyst infection in autosomal dominant polycystic kidney disease. Clin Nephrol. 2015; 84: 61–64. Ref.: https://goo.gl/4JUrij
Neuville M, Hustinx R, Jacques J, Krzesinski JM, Jouret F. Diagnostic Algorithm in the Management of Acute Febrile Abdomen in Patients with Autosomal Dominant Polycystic Kidney Disease. PLoS ONE. 2016; 11: e0161277. Ref.: https://goo.gl/zbGgUP
Fukasawa H, Kaneko M, Niwa H, Yasuda H, Kumagai H, et al. Carbohydrate antigen 19-9 is significantly elevated in autosomal dominant polycystic kidney disease. Nephrology (Carlton). 2018; 23: 210-216. Ref.: https://goo.gl/awzFJ6
Lantiga MA, Drenth JP, Gevers TJ. Diagnostic criteria in renal and hepatic cyst infection. Nephrology Dialysis Transplantation. 2015; 30: 744-7451. Ref.: https://goo.gl/p5Qjj4
Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, et al. Autosomal Dominant Polycystic Kidney Disease (ADPKD): Executive Summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney international. 2015; 88: 17-27. Ref.: https://goo.gl/RtcfYY
Suwabe T, Araoka H, Ubara Y, Kikuchi K, Hazue R, et al. Cyst infection in autosomal dominant polycystic kidney disease: causative microorganisms and susceptibility to lipidsoluble antibiotics. Eur J Clin Microbiol Infect Dis. 2015; 34: 1369–1379. Ref.: https://goo.gl/yd4XSB
Pirson Y, Chauveau D, Devuyst O. Autosomal dominant polycystic kidney disease. In: Davidson AM, editor. Oxford textbook of clinical nephrology. 3rd ed, Oxford: Oxford University Press. 2005; 2304-24.